Vaccines, blood, antisera, toxins and cultures in   Bahamas

Exports In 2022, Bahamas exported $57.9k in Vaccines, blood, antisera, toxins and cultures, making it the 139th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 182nd most exported product in Bahamas. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Bahamas are: Grenada ($37.2k), Germany ($20.5k), Trinidad and Tobago ($103), United States ($74), and Canada ($37).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Bahamas between 2021 and 2022 were Grenada ($37.2k), United States ($74), and Canada ($27).

Imports In 2022, Bahamas imported $11.5M in Vaccines, blood, antisera, toxins and cultures, becoming the 160th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 75th most imported product in Bahamas. Bahamas imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($6.65M), United States ($2.6M), Costa Rica ($795k), Panama ($265k), and South Korea ($248k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Bahamas between 2021 and 2022 were Costa Rica ($485k), Panama ($265k), and Denmark ($134k).